Patients With Acute Myeloid Leukemia andRASMutations Benefit Most From Postremission High-Dose Cytarabine: A Cancer and Leukemia Group B Study

Journal of Clinical Oncology - United States
doi 10.1200/jco.2007.14.0418
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

High Dose Cytarabine Plus Gemtuzumab Ozogamicin for Patients With Relapsed or Refractory Acute Myeloid Leukemia: Cancer and Leukemia Group B Study 19902

Leukemia Research
Cancer ResearchOncologyHematology
2011English

Cytarabine Dose for Acute Myeloid Leukemia

New England Journal of Medicine
Medicine
2011English

Outcomes of Six-Dose High-Dose Cytarabine as a Salvage Regimen for Patients With Relapsed/Refractory Acute Myeloid Leukemia

Advances in Hematology
Hematology
2017English

A Phase I Study of Selinexor in Combination With High-Dose Cytarabine and Mitoxantrone for Remission Induction in Patients With Acute Myeloid Leukemia

Journal of Hematology and Oncology
Cancer ResearchOncologyHematologyMolecular Biology
2018English

Randomized, Phase IIb Study of Low-Dose Cytarabine and Lintuzumab Versus Low-Dose Cytarabine and Placebo in Older Adults With Untreated Acute Myeloid Leukemia

Haematologica
Hematology
2012English

Low Dose Cytarabine and Cladribine for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: Clinical Experience

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2016English

A Randomized Trial of High-Versus Conventional-Dose Cytarabine in Consolidation Chemotherapy for Adult De Novo Acute Myeloid Leukemia in First Remission After Induction Therapy Containing High-Dose Cytarabine

Blood
BiochemistryImmunologyCell BiologyHematology
2005English

AAML0523: A Report From the Children's Oncology Group on the Efficacy of Clofarabine in Combination With Cytarabine in Pediatric Patients With Relapsed Acute Myeloid Leukemia

Blood
BiochemistryImmunologyCell BiologyHematology
2012English

Decitabine Compared With Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-Effectiveness

Advances in Hematology
Hematology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy